Vasohibin-1 expression is regulated by transforming growth factor-β/bone Morphogenic protein signaling pathway between tumor-Associated macrophages and pancreatic cancer cells

Journal of Interferon and Cytokine Research

Volumn 33, Issue 8, 2013, Pages 428-433

  Shen, Zhanlong ^a,b   Seppänen, Hanna ^b   Kauttu, Tuuli ^b   Vainionpää, Sanna ^b   Ye, Yingjiang ^a   Wang, Shan ^a   Mustonen, Harri ^b   Puolakkainen, Pauli ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ANGIOGENESIS INHIBITOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; LDN 193189; MESSENGER RNA; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VASOHIBIN 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER CELL CULTURE; COCULTURE; DISTANT METASTASIS; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION;

BENZAMIDES; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; DIOXOLES; GENE EXPRESSION; HUMANS; MACROPHAGES; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PYRAZOLES; PYRIMIDINES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84881469395     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0046     Document Type: Article

References (26)

1. Ebos JM, Kerbel RS. 2011 Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 8:210-221
2. Fisher WE, Berger DH. 2003 Angiogenesis and antiangiogenic strategies in pancreatic cancer. Int J Gastrointest Cancer 33:79- 88
3. Heishi T, Hosaka T, Suzuki Y, Miyashita H, Oike Y, Takahashi T, Nakamura T, Arioka S, Mitsuda Y, Takakura T, Hojo K, Matsumoto M, Yamauchi C, Ohta H, Sonoda H, Sato Y. 2010 Endogenous angiogenesis inhibitor vasohibin1 exhibits a broad-spectrum anti-lymphangiogenic activity and suppresses lymph node metastasis. Am J Patho 176:1950-1958
4. Hong S, Lee HJ, Kim SJ, Hahm KB. 2010 Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling. World J Gastroenterol 16:2080-2093
5. Hosaka T, Kimura H, Heishi T, Suzuki Y, Miyashita H, Ohta H, Sonoda H, Moriya T, Suzuki S, Kondo T, Sato Y. 2009 Vasohibin- 1 expression in endothelium of tumor blood vessels regulates angiogenesis. Am J Pathol 175:430-439
6. Jakowlew SB. 2006 Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25:435-457 (Pubitemid 44922360)
7. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003 Cancer statistics, 2003. CA Cancer J Clin 53:5-26 (Pubitemid 36163619)
8. Kerbel RS. 2004 Vasohibin: the feedback on a new inhibitor of angiogenesis. J Clin Invest 114:884-886 (Pubitemid 39578712)
9. Malmberg KJ. 2004. Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? Cancer Immunol Immunother 53:879-892
10. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. 2002. Macrophage polarization: tumor-Associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555 (Pubitemid 35223554)
11. Miyake K, Nishida K, Kadota Y, Yamasaki H, Nasu T, Saitou D, Tanabe K, Sonoda H, Sato Y, Maeshima Y, Makino H. 2009. Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts. Acta Med Okayama 63:349- 358
12. Naito H, Kidoya H, Sato Y, Takakura N. 2009. Induction and expression of anti-Angiogenic vasohibins in the hematopoietic stem/progenitor cell population. J Biochem 145:653-659
13. Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. 2009. Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. Diabetes 58:2365-2375
14. Payne SJ, Jones L. 2011. Influence of the tumor microenvironment on angiogenesis. Future Oncol 7:395-408
15. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K. 1994. Vascular endothelial growth factor is induced in response to transforming growth factor b in fibroblastic and epithelial cells. J Biol Chem 269:6271-6274 (Pubitemid 24190991)
16. Piek E, Heldin CH, Ten Dijke P. 1999. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 13:2105-2124
17. Qian BZ, Pollard JW. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51
18. Ribatti D. 2011. Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway. Cancer Treat Rev 37:344-352
19. Sato H, Abe T, Wakusawa R, Asai N, Kunikata H, Ohta H, Sonoda H, Sato Y, Nishida K. 2009. Vitreous levels of Vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetologia 52:359-361
20. Sato Y. 2006. Update on endogenous inhibitors of angiogenesis. Endothelium 13:147-155 (Pubitemid 44173114)
21. Sato Y. 2009. Delta-like 4 and vasohibin 1: two endotheliumproduced negative regulators of angiogenesis with distinctive roles. Eur Cytokine Netw 20:220-224
22. Sgambato A, Cittadini A. 2010. Inflammation and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci 14:263-268
23. Stearns ME, Garcia FU, Fudge K, Rhim J, Wang M. 1999. Role of interleukin 10 and transforming growth factorb1 in the angiogenesis and metastasis of human prostate primary tumor cell lines from orthotopic implants in severe combined immunodeficiency mice. Clin Cancer Res 5:711-720 (Pubitemid 29131984)
24. Watanabe K, Hasegawa Y, Yamashita H, Shimizu K, Ding Y, Abe M, Ohta H, Imagawa K, Hojo K, Maki H, Sonoda H, SatoY. 2004. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest 114:898-907 (Pubitemid 39578717)
25. Wissmann C, Detmar M. 2006. Pathways targeting tumor lymphangiogenesis. Clin Cancer Res 12:6865-6868 (Pubitemid 44974477)
26. Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H, Yaegashi N, Sato Y. 2008. Expression of vasohibin as a novel endothelium derived angiogenesis inhibitor in endometrial cancer. Cancer Sci 99:914-919. (Pubitemid 351997593)